Feeding Mom Feeding Infant's Microbiota: Nutritional Strategies for Improving Breast Milk Composition and Infant Health
NCT ID: NCT05259059
Last Updated: 2024-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2022-04-19
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Nutrients Composition of Breast Milk of Chinese Lactating Mothers and Their Nutrition Intake
NCT01971671
Effectiveness of an Early Nutrition Program on Promoting Breastfeeding and Optimizing Infant Growth and Diet Quality
NCT03493594
Impact of Breast Milk miRNAs on the Infant Gut Microbiota
NCT06651216
Professional Breastfeeding Support Intervention
NCT01893736
A Cohort Study on Milk Composition, Health Outcomes, and Feeding Practices of Chinese Mothers and Infants
NCT05235412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In recent decades, accumulating evidence shows that gut microbiota plays indispensable roles in programming the growth, immunity and metabolic capacity of a person since birth. In addition, gut microbiota also exerts a significant impact on the disease risks at a later life stage, e.g., the development of obesity and cardiometabolic disorders. As such, factors (e.g., breast milk composition, exposure to antibiotics) that influence the initial establishment of gut microbiome during infancy and childhood should be carefully considered and optimized. It has now been determined that breast milk, as the sole nutrient source for infant, has a major impact in shaping early gut microbiota. However, there is still limited understanding on the complex interplay among maternal diet, feeding practices and infant health outcomes including the gut microbiota which are keys to the infant's developmental trajectory.
Maintaining a balanced diet with varieties of food is important to both the lactating mother and her child. In addition to rich nourishment from animal-based foods, plant-based diet provides an additional wide array of nutrients and bioactive components. First, dietary fiber, abundant in multiple plant-based foods, is beneficial to metabolic health, strengthening oxidative defense and profile of blood glucose, insulin sensitivity and blood lipid. Through the fermentation of gut microbiota in distal intestine, dietary fiber can be converted into multiple types of short chain fatty acids (SCFAs), which are involved in multiple physiological functions, and may enhance gut microbiota diversity and functionality. Second, as many bioactive phytochemicals are bound to macromolecules such as polysaccharides, fiber-rich foods are also good sources of phyto-nutrients including polyphenols and carotenoids. As well referenced before, flavonoids and carotenoids are established biomarkers for the intake of fruits and vegetables whose metabolites can be found in urine and breast milk. In the investigators' pilot analysis among nine lactating women, the investigators have found a significant inverse correlation between fiber intake during late trimester and infants' stool microbiota abundance of Firmicutes at 2nd month postpartum, the phylum of bacteria which might relate to a lower risk of cardiometabolic diseases. However, how maternal intake of plant-based foods affects the production and composition of breast milk in lactating women and the infant's gut microbiome is yet to be clarified.
Through increasing the intake of plant-based foods for lactating women, it may also provide micronutrients that are important for infants. For instance, omega-3 fatty acids and vitamin A are essential nutrients for infants' visual development. Flaxseed oils, walnuts and chia seeds are the common plant-based sources of alpha-linoleic acid, the precursor of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). DHA is highly concentrated in the photoreceptor outer segment membranes of the retina, and is essential for visual function. Apart from omega-3 fatty acids, vitamin A involves in visual transduction and the formation of visual pigments. Vitamin A is a group of organic compounds that includes retinol, retinal, and several provitamin A (carotenoids), which can be commonly found in orange and yellow vegetables and fruits (e.g. carrots, peaches, corns), and most dark green, leafy vegetables. Several carotenoids (beta-carotene, lutein, ß-cryptoxanthin and zeaxanthin) may reduce the long-term risk of cataract.
Despite the important role of maternal nutrition during pregnancy and breastfeeding periods and the long-term health of both mother and the offspring, there has been limited data in Hong Kong. In the investigators' pilot study among 64 mother-child pairs, the investigators examined the maternal diet in late pregnancy and found that only 10.0% and 25.0% of participating mothers have met the dietary recommendation on dietary fiber (25 grams/day) and vitamin A (770 μg of retinol activity equivalents/day) intake. Although the results might not fully represent the Hong Kong population, the inadequate intake of dietary fiber from plant-based foods for Hong Kong mothers warrants concern.
In the recent years, the Hong Kong society has increasing awareness on the importance of breastfeeding, and the initiation rate for breastfeeding was 87.5% in 2018. The improved rate of breastfeeding has been attributed by the collaborative efforts from various healthcare professionals, including physicians, nurses and lactating consultants, through the delivery of training sessions and frequent follow-up. However, the focus in current practice in clinical setting is to initiate and maintain breastfeeding practice, but fewer attention has been paid to optimize the nutrient composition in breast milk. Given that vitamin A is transferred to offspring by limited placental transfer during gestation, and mostly through breast milk during lactation, inadequate maternal intake of vitamin A and/or provitamin A may put infants at risk of deficiency. In another pilot study, the investigators have compared retinol and selected carotenoid contents in breast milk from 92 Hong Kong lactating mothers with high (3.0 servings/day on average) or low (1.2 servings/day on average) vegetable intakes, and mothers that consumed ß-carotene-containing supplements (2.4 servings of vegetables/day on average). The results showed that supplement users had significantly higher ß-carotene and retinol levels in breast milk, while mothers with higher vegetable intakes had significantly higher lutein levels in breast milk, and vegetable intake significantly correlated with the availability of lutein, ß-carotene, and lycopene in breast milk. Taken together, improving maternal diet may provide better nutrient composition in breast milk, and prevent low nutritional status of mothers.
In brief, many previous studies on the relationship between maternal diet, bioactive components in breast milk and infant health outcomes were cross-sectional in nature, while the inter-relationships between maternal diet, breast milk composition, infant gut microbiota and infant development warrants further clarification. How maternal dietary factors and infant feeding practices during the early life may influence the health outcomes infants is another perspective that worth examination. From the perspective of nutritional epidemiology, a high-quality prospective cohort will be needed to provide strong evidence to verify food-based dietary practices for postpartum women (e.g., the consumption of whole-grain cereals, fruits, and vegetables as recommended by the World Health Organization Global Strategy on Diet, Physical Activity, and Health) that may improve the general health of mothers and their children. Therefore, the investigators proposed a prospective cohort to uncover the underlying linkage among maternal diet, breast milk composition, gut microbiota and infant developmental conditions through a multi-omics approach.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention is involved
No intervention is involved
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Vaginal delivery between 37 and 42 weeks of gestation;
3. Carrying a singleton pregnancy;
4. Breastfeeding for \>80% feeding occasions upon recruitment;
5. Intend to continue breastfeeding at least till the infant reaches 3-month old;
1. Delivered between 37 and 42 weeks;
2. Born by vaginal delivery;
3. Singleton infant with no known abnormality;
Exclusion Criteria
2. Special dietary restrictions for examples gluten-free diets, vegan or any restrictions due to food allergies;
3. Suffer from renal, liver, or thyroid dysfunction, cognitive impairment, or any other indication of a major medical or psychological illness, as judged by the investigators as ineligible to participate the study
4. Have no intention to continue breastfeeding beyond 3 months.
1 Month
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Hong Kong Polytechnic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. WONG Man Sau
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Man Sau Wong, PhD
Role: PRINCIPAL_INVESTIGATOR
The Hong Kong Polytechnic University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Hong Kong Polytechnic University
Hong Kong, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSEARS20211018004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.